Sonoma Biotherapeutics

Sonoma Biotherapeutics

Sonoma Biotherapeutics

We have innovative science originating from our founders worldclass labs and a unique and disruptive approach to research and development.
Type
B2b
Raised
$40M
Follow us
Alexa global traffic share
Latest funding
$40,000,000
Venture capital (Series A) - 2020
ARCH Venture Partners Milky Way Ventures 8VC +1
Team Size
1–10
Employees
$40,000,000 Venture capital (Series A)
Pulse 2.0

T Cell Therapy Company Sonoma Biotherapeutics Raises $40 Million